Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Puliani

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
European Journal of Endocrinology|May 9, 2025
Circulating immune cell profile in patients with acromegaly: results from the PROMISE, a prospective clinical trialTiziana Feola, Dario De Alcubierre, Giulia Puliani, et al.
International Journal of Obesity (2005)|July 21, 2023
Pituitary T1 signal intensity at magnetic resonance imaging is reduced in patients with obesity: results from the CHIASM studyGiulia Puliani, Emilia Sbardella, Alessia Cozzolino, et al.
Endocrine|January 28, 2022
Angiogenic factors as prognostic markers in neuroendocrine neoplasmsGiulia Puliani, Franz Sesti, Emanuela Anastasi, et al.
Endocrine|September 29, 2023
Thyroid transcription factor-1 expression in lung neuroendocrine tumours: a gender-related biomarker?Anna La Salvia, Alessandra Siciliani, Maria Rinzivillo, et al.
European Thyroid Journal|April 8, 2025
Gender impact on safety and efficacy in lenvatinib treated patients with radioiodine-refractory differentiated thyroid cancer (GISEL study)Giulia Puliani, Marta Bianchini, Carlotta Giani, et al.
Journal of Clinical Medicine|October 14, 2022
Angioside: The role of Angiogenesis and Hypoxia in Lung Neuroendocrine Tumours According to Primary Tumour Location in Left or Right ParenchymaAnna La Salvia, Raffaella Carletti, Monica Verrico, et al.
Journal of Neuroendocrinology|December 27, 2024
Impact of dyslipidemia and lipid-lowering therapy with statins in patients with neuroendocrine tumorsAntongiulio Faggiano, Flaminia Russo, Virginia Zamponi, et al.
Endocrine|March 18, 2022
Prognostic significance of laterality in lung neuroendocrine tumorsAnna La Salvia, Irene Persano, Alessandra Siciliani, et al.
Reviews in Endocrine & Metabolic Disorders|September 16, 2020
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell?Giovanni Vitale, Alessandra Dicitore, Luigi Barrea, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
European Journal of Endocrinology|May 9, 2025
Circulating immune cell profile in patients with acromegaly: results from the PROMISE, a prospective clinical trialTiziana Feola, Dario De Alcubierre, Giulia Puliani, et al.
International Journal of Obesity (2005)|July 21, 2023
Pituitary T1 signal intensity at magnetic resonance imaging is reduced in patients with obesity: results from the CHIASM studyGiulia Puliani, Emilia Sbardella, Alessia Cozzolino, et al.
Endocrine|January 28, 2022
Angiogenic factors as prognostic markers in neuroendocrine neoplasmsGiulia Puliani, Franz Sesti, Emanuela Anastasi, et al.
Endocrine|September 29, 2023
Thyroid transcription factor-1 expression in lung neuroendocrine tumours: a gender-related biomarker?Anna La Salvia, Alessandra Siciliani, Maria Rinzivillo, et al.
European Thyroid Journal|April 8, 2025
Gender impact on safety and efficacy in lenvatinib treated patients with radioiodine-refractory differentiated thyroid cancer (GISEL study)Giulia Puliani, Marta Bianchini, Carlotta Giani, et al.
Journal of Clinical Medicine|October 14, 2022
Angioside: The role of Angiogenesis and Hypoxia in Lung Neuroendocrine Tumours According to Primary Tumour Location in Left or Right ParenchymaAnna La Salvia, Raffaella Carletti, Monica Verrico, et al.
Journal of Neuroendocrinology|December 27, 2024
Impact of dyslipidemia and lipid-lowering therapy with statins in patients with neuroendocrine tumorsAntongiulio Faggiano, Flaminia Russo, Virginia Zamponi, et al.
Endocrine|March 18, 2022
Prognostic significance of laterality in lung neuroendocrine tumorsAnna La Salvia, Irene Persano, Alessandra Siciliani, et al.
Reviews in Endocrine & Metabolic Disorders|September 16, 2020
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell?Giovanni Vitale, Alessandra Dicitore, Luigi Barrea, et al.
Pageof 5